NephroQuiz: a fishy rash.

NephroQuiz is curated by BMC Nephrology Editorial Board Members from Johns Hopkins University, Dr. Hanouneh and Dr. Cervantes. It aims to engage readers with clinical vignettes and problem solving. The USMLE-style questions are designed to test knowledge and engage with published literature.
NephroQuiz: a fishy rash.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

A 51-year-old man presented for evaluation of a newly developed rash (xerosis with hyperpigmented scaly lesions on his arms, legs, abdomen, and back). Skin biopsy showed hyperkeratosis with non-necrotising granulomas. He had no medical history, did not report any nausea, vomiting, chest pain, dyspnea, or urinary symptoms. On examination his blood pressure was 125/75 mmHg, pulse rate was 85 beats per minute, and his oxygen saturation was 96%.  

Laboratory investigations showed creatinine 6.27 mg/dL (normal range 0.67–1.17; a baseline measurement 2 months before he presented was 0.9), sodium 137 mmol/L (normal range 136–145), potassium 3.8 mmol/L (normal range 3.5–5.1), bicarbonate 22 mmol/L (normal range 22–29), calcium 15.1 mg/dL (normal range 8.6–10.2), albumin 4.3 g/dL (normal range 3.5–5.2), ionized calcium 1.91 mmol/L (normal range 1.17–1.38), parathyroid hormone (PTH) 9.1 pg/mL (normal range 18.4–80.1), PTH-related protein 3.4 pmol/L (normal range 0.0–2.3), 1,25-dihydroxyvitamin D 97.3 pg/mL (normal range 19.9–79.3), and angiotensin-converting enzyme 120 U/L (normal range 16–85).

Urinalysis was positive for proteinuria with a urine protein-to-creatinine ratio of 0.92. Further serology workup showed the following: negative hepatitis B virus, hepatitis C virus, and HIV serologies, normal C3 and C4, undetectable antinuclear antibodies (ANAs), anti-double stranded DNA antibodies titer of <1:10 (normal <1:10), negative antineutrophil cytoplasmic antibodies (ANCAs), serine protease 3 antibodies (PR3-ANCAs) titer of 0 AU/mL (normal 0–19), myeloperoxidase antibodies (MPO) titer of 0 AU/mL (normal 0–19), and phospholipase A2 receptor (PLA2R) antibody titer of <1:10 (normal <1:10).

Kidney biopsy (shown above) was performed with: light microscopy hematoxylin and eosin stain (A), light microscopy periodic acid methenamine silver stain (B), IgG Immunofluorescence microscopy (C), electron microscopy (D). 

The correct answer and explanation will be revealed once you select an answer in the multiple choice question above. 

Click here to read the original case report. We encourage discussion of the case and questions in the comments. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Nephrology
Life Sciences > Health Sciences > Clinical Medicine > Nephrology
  • BMC Nephrology BMC Nephrology

    This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Related Collections

With collections, you can get published faster and increase your visibility.

Novel devices in hemodialysis

BMC Nephrology invites submissions to our Collection on Novel devices in hemodialysis.

Hemodialysis is a life-saving treatment for individuals with kidney failure, but it often requires frequent visits to dialysis centers, posing challenges for patients. The development of novel devices in hemodialysis, including wearable and portable technologies, has the potential to revolutionize renal health care by offering more convenient and efficient treatment options. These devices encompass a wide range of technological advancements, such as wearable artificial kidneys, advanced dialyzers, and home-treatment solutions, aiming to improve the quality of life for patients undergoing hemodialysis.

It is important to continue advancing our collective understanding in this area to address the unmet needs of individuals with kidney failure and to enhance the accessibility and effectiveness of hemodialysis. Recent advances in novel devices have shown promising results in improving the portability and efficiency of hemodialysis, allowing for more flexible treatment schedules and reducing the burden on patients. Additionally, these innovations have the potential to lower healthcare costs and improve patient outcomes, making hemodialysis more sustainable and accessible.

Topics of interest for this Collection include, but are not limited to:

• Wearable and portable hemodialysis devices

• Technological advancements in dialysis treatment

• Impact of novel devices on patient outcomes

• Home-treatment solutions for hemodialysis

• Artificial intelligence and machine learning applications in hemodialysis monitoring and treatment optimization

• 3D printing technology for personalized dialysis device fabrication

• Telemedicine and remote monitoring for home-based hemodialysis care

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 9: Industry, Innovation, and Infrastructure.

Publishing Model: Open Access

Deadline: Jul 29, 2025

Lifestyle modifications for preventing kidney disease

BMC Nephrology invites new submissions on Lifestyle modifications for preventing kidney disease.

Chronic kidney disease (CKD) is a significant public health challenge, with lifestyle factors playing a crucial role in its prevention and management. Lifestyle modifications, including dietary changes, physical activity, weight management, and smoking cessation, have been identified as important strategies for reducing the risk of kidney disease and slowing its progression. Research in this area has highlighted the impact of lifestyle interventions on kidney health, emphasizing the potential for preventive measures to alleviate the burden of CKD.

Recent advances demonstrate the effectiveness of lifestyle interventions in reducing the risk of CKD and improving outcomes for individuals with kidney disease. Additionally, research has underscored the importance of multidisciplinary approaches that integrate lifestyle modifications into routine clinical care, promoting holistic kidney health.

Looking ahead, continued research in this area holds the potential for identifying personalized lifestyle interventions tailored to individual risk factors and cultural contexts. Furthermore, ongoing research efforts may lead to the development of innovative digital health tools and mobile applications that support individuals in adopting and sustaining healthy lifestyle behaviors to prevent kidney disease.

Topics of interest include, but are not limited to:

• Dietary interventions for kidney disease prevention

• Exercise and physical activity in CKD management

• Smoking cessation and its impact on kidney health

• Lifestyle modifications for reducing blood pressure and preventing CKD

• The role of mindfulness and stress reduction techniques in preventing kidney disease

• Impact of sleep quality and duration on kidney health

• Evaluating the effectiveness of community-based lifestyle interventions in preventing CKD

• Exploring the influence of socioeconomic factors on lifestyle modifications and kidney disease prevention

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Dec 12, 2025